600895 张江高科
2024/06 - 中期
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入1,225,365126.54%2,025,7381,906,7192,097,062779,198
减:营业总成本984,25596.79%1,546,1101,584,6581,190,101783,929
    其中:营业成本488,959170.94%849,930722,776644,690349,808
               财务费用275,21927.76%456,588420,670392,817323,080
               资产减值损失----(3,443)(4,747)(106)(732)
公允价值变动收益178,47133.42%645,235531,567626,835208,564
投资收益(103,814)-131.76%205,936119,369(487,013)2,311,933
    其中:对联营企业和合营企业的投资收益(156,677)-28.03%(515,884)(40,711)(837,862)2,189,418
营业利润319,731-36.90%1,347,5031,000,5031,073,0372,558,259
利润总额319,284-36.95%1,311,856933,263872,5562,368,158
减:所得税费用69,371-37.94%371,210145,618224,246635,505
净利润249,912-36.67%940,646787,645648,3101,732,653
减:非控股权益(16,358)-817.63%(7,254)(34,571)(92,312)(89,429)
股东净利润266,270-32.13%947,900822,216740,6221,822,082

市场价值指针
每股收益 (元) *0.170-32.00%0.6100.5300.4801.180
每股派息 (元) *0.052--0.1900.1600.1500.360
每股净资产 (元) *8.0254.12%8.0347.5627.0346.977
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容